pluripotent stem cell (PSC)-derived therapies

This lineup at ISSCR 2026 provides comprehensive coverage across the Pluripotent Stem Cell (PSC) -derived cell therapy pipeline, from preclinical to clinical translation and commercial manufacturing, as well as enabling technologies for the next breakthrough.

Brian Bigger, PhD

The University of Edinburgh, UK
Presenting in Integrating Gene and Cell Approaches for Transformative Therapies
Anders Bjorklund, MD, PhD

Wallenberg Neuroscience Center, Lund University, Sweden
Presenting in Plenary I: Presidential Symposium
Debojyoti Chakraborty, PhD

CSIR-Institute of Genomics and Integrative Biology, India
Presenting in Plenary IV: Clinical Advances
Faranak Fattahi, PhD

University of California, San Francisco, USA
Presenting in Modeling Cellular Complexity for Tissue Therapies
Michael G. Fehlings, MD, PhD,

University of Toronto & Toronto Western Hospital, Canada
Presenting in Integrating Gene and Cell Approaches for Transformative Therapies
Yukiko S. Gotoh, PhD

University of Tokyo, Japan
Presenting in Plenary I: Presidential Symposium
Michael A. Laflamme, MD, PhD

McEwen Stem Cell Institute, University Health Network, Canada
Presenting in Tissue Repair and Regeneration in Common Diseases
Madeline Lancaster, PhD

Medical Research Council (MRC), UK
Presenting in Plenary I: Presidential Symposium
Wendell A. Lim, PhD

University of California San Francisco, USA
Presenting in Engineering Cell Fate in Biological Systems
Martine Rothblatt, JD, PhD

United Therapeutics, USA
Presenting in Plenary IV: Clinical Advances and the Promise for Patients
Guy Sauvageau, PhD

Institute for Research in Immunology & Cancer, Université de Montréal, Canada
Presenting in Modulating the Tissue Niche for Therapeutic Success
Nobukatsu Sawamoto, MD, PhD

Kyoto University, Japan
Presenting in Modulating the Tissue Niche for Therapeutic Success
Mark Skylar-Scott, PhD

Stanford University, USA
Presenting in Biomanufacturing Stem Cell Therapies
Sarah J. Tabrizi, FMedSci, FRS

University College London, UK
Presenting in Plenary IV: Clinical Advances and the Promise for Patients
Susan N. Thomas, PhD

Georgia Institute of Technology, USA
Presenting in Tissue and Organoid Engineering
Peter Zandstra, PhD, FRSC, PEng

The University of British Columbia, Canada
Presenting in Engineering Cell Fate in Biological Systems
Feng Zhang, PhD

Broad Institute of MIT and Harvard, USA
Presenting in Plenary I: Presidential Symposium

Explore other scientific topics covered at ISSCR 2026